High-dose vitamin C supplements can raise the risk of kidney stones, but the relationship is more complicated than a blanket warning suggests. The clearest evidence points to men taking 1,000 mg or more per day from supplements, where large studies have found a meaningful increase in stone risk. Women, oddly, don’t seem to face the same elevated risk at the same doses. And roughly 40% of people appear to be metabolic “responders” whose bodies convert more vitamin C into oxalate, the main ingredient in the most common type of kidney stone, while others barely budge. The real answer depends on dose, sex, kidney function, and individual biology.
How Vitamin C Turns Into a Stone-Forming Chemical
Most kidney stones are made of calcium oxalate. Your body produces oxalate on its own, and you also absorb it from foods like spinach, nuts, and chocolate. Vitamin C adds a third source: when your body is done using it, the leftover ascorbic acid breaks down through a non-enzymatic process that produces oxalate as a byproduct.1PubMed Central. Ascorbic acid intake and oxalate synthesis At normal dietary intakes, this contribution is small. But when you take large supplemental doses, the extra vitamin C that your body can’t use gets excreted, and more of it converts to oxalate along the way.
Whether that extra oxalate actually reaches your urine in meaningful amounts has been debated for decades. One study examining dietary risk factors in stone formers found that vitamin C intake was significantly associated with urinary oxalate excretion, alongside fluid intake, and that calcium intake was inversely related.2Kidney International. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers So the biochemical pathway from supplement to oxalate to urine is real. The question is how much it matters in practice.
The Measurement Problem That Muddied the Science for Years
For a long time, researchers disagreed about whether vitamin C supplements actually raised urinary oxalate. Part of the confusion came from the lab itself. When a urine sample containing leftover vitamin C sits in a collection jug or gets processed in a lab, some of that vitamin C can convert to oxalate during the analytical procedure. That means the test shows more oxalate than was actually in the person’s urine when they produced it.
One older study tested this directly by giving subjects 1, 5, and 10 grams of supplemental vitamin C per day for five-day stretches. Even at those enormous doses, the apparent increases in urinary oxalate were modest and could be entirely accounted for by oxalate forming during lab processing rather than inside the body.3PubMed. Effect of high dose vitamin C on urinary oxalate levels Separate in vitro work confirmed that under controlled conditions, new oxalate didn’t form from ascorbic acid the way some researchers feared.4PubMed. Ascorbic acid in idiopathic recurrent calcium urolithiasis in humans–does it have an abettor role in oxalate, and calcium oxalate crystallization?
This artifact problem led some scientists to conclude that vitamin C was essentially harmless to stone risk. More recent studies that carefully controlled for this issue, using methods that stabilize urine samples before vitamin C can break down in the collection container, still found real increases in oxalate. The measurement confusion is worth knowing about because it explains why you’ll find contradictory-sounding headlines depending on which era of research you’re reading.
What Large Studies Show About Actual Stone Formation
The most telling evidence comes not from measuring oxalate in urine cups but from tracking whether real people actually develop stones. Two large prospective studies stand out, and they agree on a striking pattern: the risk increase shows up in men but not in women.
A Swedish study following men for 11 years found that those who regularly took vitamin C supplements had roughly double the risk of developing a first kidney stone compared to men who didn’t supplement. Men taking seven or more vitamin C tablets per week had a particularly elevated risk. Multivitamin use, by contrast, was not associated with increased stone risk.5JAMA Internal Medicine. Ascorbic Acid Supplements and Kidney Stone Incidence Among Men: A Prospective Study
A separate analysis pooling data from two large U.S. cohorts reinforced this finding. Among men, total vitamin C intake of 1,000 mg per day or more was associated with about a 40% higher risk of kidney stones compared to intakes below 90 mg. Supplemental vitamin C at 1,000 mg or more per day was also linked to higher risk. Among women, however, neither total nor supplemental vitamin C intake at any dose was significantly associated with stone risk.6PubMed Central. Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones Vitamin C from food alone (as opposed to supplements) was not associated with stones in either sex, though few people reach very high intakes through diet alone.
Why men and women differ remains unclear. Estrogen may play a protective role in oxalate metabolism, or the difference could relate to body size, fluid intake habits, or other confounders that large observational studies struggle to fully separate. Whatever the explanation, the sex difference is consistent enough across studies that it seems real rather than a statistical fluke.
Not Everyone Responds the Same Way
One of the more interesting findings in this area is that people vary dramatically in how much oxalate they produce from a given dose of vitamin C. A controlled study giving participants 1,000 mg of ascorbic acid twice daily found that about 40% were “responders” who saw a meaningful jump in both oxalate excretion and a risk index for calcium oxalate stones. The responders showed roughly a 31% increase in the percentage of oxalate they absorbed and a 39% increase in the amount of oxalate their bodies synthesized internally. The other 60% were relative non-responders.7The Journal of Nutrition. Ascorbate Increases Human Oxaluria and Kidney Stone Risk Both stone formers and people with no history of stones were found among the responders, meaning you can’t predict who will react just by knowing their stone history.
This responder phenomenon may explain some of the conflicting study results. If you average oxalate changes across a mixed population, the 60% of non-responders dilute the signal from the 40% who are actually at risk. The effect looks modest on average even though it’s substantial in the people who matter. The trouble is that there’s no simple clinical test right now to tell whether you’re a responder before you start supplementing. The underlying variation probably comes from differences in gut bacteria, liver enzyme activity, and genetic factors that influence how each person metabolizes ascorbic acid.
What Happens in People With Kidney Disease
Healthy kidneys filter and excrete oxalate reasonably well, so even a moderate rise in oxalate production doesn’t necessarily cause problems. But when kidney function is impaired, the math changes. People on dialysis can’t clear oxalate efficiently, so it accumulates in the blood and can deposit in tissues throughout the body.
Patients on hemodialysis who received relatively low intravenous doses of vitamin C (250 to 500 mg per week, used to treat the anemia that often accompanies kidney failure) still saw their plasma oxalate levels climb. At the 500 mg weekly dose, 40% of patients exceeded the threshold at which calcium oxalate starts to crystallize out of solution.8American Journal of Kidney Diseases. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients A case report described a peritoneal dialysis patient who developed systemic oxalosis, with oxalate crystals depositing in the eyes and joints, after long-term high-dose vitamin C use.9American Journal of Kidney Diseases. Oxalosis Associated With High-Dose Vitamin C Ingestion in a Peritoneal Dialysis Patient
Children on dialysis face similar dangers. A study of 13 infants and young children receiving dialysis found that their nutritional support formulas were providing anywhere from 145% to 847% of the age-appropriate recommended vitamin C intake. Both their ascorbic acid and plasma oxalate levels were elevated.10PubMed. Vitamin C overload may contribute to systemic oxalosis in children receiving dialysis For anyone with significantly reduced kidney function, even doses that would be harmless in a healthy person can allow dangerous oxalate buildup.
Intravenous Vitamin C Is a Different Risk Category
When vitamin C is given intravenously rather than swallowed, the doses can be far higher than anything you’d absorb from a pill. Your gut limits how much oral vitamin C reaches the bloodstream (absorption drops sharply above a few hundred milligrams at a time), but an IV bypasses that bottleneck entirely. This makes high-dose IV vitamin C, sometimes used in alternative cancer therapy or in intensive care settings, a more acute concern for kidney damage.
Case reports describe patients developing sudden, severe kidney injury after IV vitamin C. One septic patient who received IV vitamin C as part of a treatment regimen developed complete kidney failure requiring dialysis. A biopsy showed extensive damage with calcium oxalate crystals lodged inside the kidney tubules.11PubMed Central. Vitamin C-Induced Oxalate Nephropathy in a Septic Patient Another case involved a patient with lupus who developed acute oxalate nephropathy after receiving intravenous vitamin C.12PubMed. Oxalate nephropathy and intravenous vitamin C These are individual case reports rather than population-level data, so they don’t tell us how often this happens. But they demonstrate that the mechanism is real: flood the body with vitamin C, overwhelm the kidneys’ ability to handle the resulting oxalate, and crystals form where they shouldn’t.
How Dose and Duration Shape the Risk
Studies that have directly measured urinary oxalate after vitamin C supplementation in controlled settings consistently find that 1 to 2 grams per day produces a real, if moderate, rise. One study gave both stone formers and healthy volunteers either 1 or 2 grams of vitamin C and found significant increases in urinary oxalate in both groups. Among stone formers, oxalate went from about 31 to 50 mg per 24 hours at the 1 gram dose and from about 34 to 48 mg at the 2 gram dose. Healthy subjects showed similar increases. A risk index for calcium oxalate crystallization also rose significantly in both groups at both doses.13Kidney International. Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients
A different study focusing on 2 grams daily found a 20% increase in urinary oxalate among people with no stone history and a 33% increase among stone formers. The researchers recommended capping vitamin C at less than 2 grams daily for anyone with a history of calcium oxalate stones.14PubMed. Effect of ascorbic acid consumption on urinary stone risk factors Meanwhile, research on actual urine crystallization after megadose vitamin C found that the calcium oxalate supersaturation and crystallization risk index both increased during supplementation, and large calcium oxalate crystals were visible under microscopy.15PubMed. Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C
Duration also matters. A case report described a 9-year-old boy who developed a ureteral stone after taking high-dose vitamin C supplements since age 3. After stopping the supplements without any other treatment, his urinary oxalate returned to normal and he had no stone recurrence over three years of follow-up.16Urology. High-dose Supplementation With Vitamin C–induced Pediatric Urolithiasis: The First Case Report in a Child and Literature Review Long-term daily supplementation at high doses appears riskier than occasional use, which makes intuitive sense: kidney stones form from sustained supersaturation, not brief spikes.
Whether the Form of Vitamin C Matters
Most vitamin C supplements contain plain ascorbic acid, but some products use buffered or metabolite-containing forms. A preliminary crossover study compared standard ascorbic acid against a vitamin C formulation containing metabolites (marketed as Ester-C) and found that the metabolite form significantly reduced urinary oxalate levels compared to plain ascorbic acid.17Urologic Nursing. Vitamin C with metabolites reduce oxalate levels compared to ascorbic acid: a preliminary and novel clinical urologic finding This is a single small study and hasn’t been widely replicated, so it would be premature to treat it as settled science. But it raises the possibility that how vitamin C is formulated could influence the amount of oxalate it generates.
Vitamin C from whole foods, for what it’s worth, doesn’t appear to carry the same risk as supplements. The large cohort analyses found that dietary vitamin C was not associated with stones in men or women.6PubMed Central. Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones This likely reflects the fact that it’s hard to get more than a few hundred milligrams of vitamin C per day from food, even with a citrus-heavy diet, and that food comes packaged with water, fiber, and other nutrients that may offset the oxalate contribution.
Where the Official Guidelines Land
Government dietary guidelines in the U.S. set the tolerable upper intake for vitamin C at 2,000 mg per day for adults, primarily based on the gastrointestinal side effects (diarrhea and cramping) that most people experience above that level. The kidney stone risk wasn’t the primary driver of that limit, partly because the evidence was still being sorted out when those guidelines were written. A review examining the evidence for establishing an upper limit noted that intakes of 2 to 4 grams per day appeared biologically well tolerated in healthy people and that strong scientific evidence to define a firm ceiling was not available at the time.18PubMed. Biomarkers for establishing a tolerable upper intake level for vitamin C
Since then, the epidemiological data linking supplements above 1,000 mg to stone risk in men has strengthened the case for caution. Most urologists and nephrologists now advise patients with a history of calcium oxalate stones to keep supplemental vitamin C below 1,000 mg daily, and some recommend staying well under that. For people with no stone history and normal kidney function, moderate supplementation in the range of a few hundred milligrams is unlikely to cause problems. The risk becomes meaningful when doses climb above 1,000 mg per day, when they’re sustained over months or years, or when the person already has compromised kidneys.
Practical Steps for People Who Want to Keep Supplementing
If you take vitamin C supplements and want to minimize any stone risk, a few practical strategies are worth considering. Staying well hydrated dilutes urinary oxalate, which lowers the chance of crystals forming regardless of the source. Keeping your calcium intake adequate (from food, not necessarily supplements) also helps, because dietary calcium binds oxalate in the gut and reduces how much reaches your kidneys. Splitting a large daily dose into smaller amounts taken throughout the day can reduce the peak oxalate load your kidneys handle at any one time, since your gut absorbs a smaller fraction of vitamin C as the dose in a single sitting increases.
Men appear to be at higher risk than women for vitamin C-related stones, so a man with any additional risk factors for stones (family history, prior stones, chronic dehydration, high-sodium diet) should be more cautious. Anyone with reduced kidney function should discuss vitamin C supplementation with their doctor, because even moderate doses can lead to oxalate accumulation when the kidneys can’t clear it normally. And for most people, getting vitamin C from fruits and vegetables rather than pills sidesteps the issue almost entirely, since dietary amounts rarely reach the threshold where stone risk has been demonstrated.